Fig 1: SVD-1a disassembles small α-syn PFF seeds into α-syn monomers.Small α-syn PFF seeds were prepared as described previously. 100 or 200 nM monomer equivalent small α-syn PFF seeds were incubated with or without 400, 500, 1600 nM SVD-1a for 3 days at 37 °C in PBS pH 7.4. A and B Time-dependent DLS measurements with 200 nM small α-syn PFF seeds in the absence (A) and presence (B) of 500 nM SVD-1a. 1 ml sample was continuously measured in a sealed quartz cuvette at 37 °C under quiescent conditions every 60 s for 72 h in a SpectroSize 300 instrument (XtalConcepts, GE). Data are shown as a radius plot where the signal amplitude of each particle size is represented by the data point diameter. C One-phase exponential decay fit of “200 nM PFF + 500 nM SVD-1a” shown in (B). Fit was performed for particles in the range of 1–100 nm with an amplitude > 0.2. Outliers were excluded from fitting using a Q value of 1%. Fitting results: Span = 23.38 nm, rate constant = 0.132 1/s; half-life = 5.2 h. Fitting was performed using the “One phase exponential decay” fitting function from GraphPad Prism 10 (GraphPad Software Inc., USA). SVD-1a does not precipitate small α-syn PFF seeds as demonstrated by protein quantification after centrifugation, shown in Supplementary Fig. 12. D For AFM analysis, small α-syn PFF seeds pretreated with or without 400 and 1600 nM SVD-1a were incubated and dried on a freshly cleaved mica surface, followed by washing with ddH2O and drying using a gentle stream of N2. Analysis was performed using the NanoWizard 3 system (J-1100, JPK BioAFM, USA), recording multiple surface sections. The sections shown are representative of the observed species and particle density identified on all surface sections. E Exemplary Western blot of small α-syn PFF samples incubated with SVD-1a. 200 nM small α-syn PFFs (monomer equivalent) were incubated with increasing concentrations of SVD-1a for 72 h at 37 °C. PFF and monomer samples that were incubated without SVD-1a served as controls. α-Syn was detected with the antibody Syn211. A prominent α-syn monomer band was present at the expected molecular weight. Below the monomer bands, no further bands were visible. In the upper part of the blot, above the marker range, PFFs were detected, using a longer exposure time due to a weaker signal (see Supplementary Fig. 11 for the whole blot image with different exposure times). F Size-based fractionation by centrifugal concentration followed by ELISA quantification. 200 nM small α-syn PFF (monomer equivalent) were incubated with or without SVD-1a together with a 200 nM monomer control for 72 h at 37 °C. After incubation, the samples were fractioned using a 100 kDa MWCO centrifugal concentrator (Merck, Microcon DNA Fast Flow 100 MWCO). α-Syn content of flow through (red) and retentate (blue) was quantified using an α-syn specific ELISA (BioLegend, Human α-Synuclein (Colorimetric), 448607). Shown are the fractions of the retentate and flow through as a percentage of the total concentration identified for each sample. A linear regression line (blue or red dotted lines) was included for the SVD-1a-treated samples (left) to underline the concentration dependency of the SVD-1a treatment effect. The fractions identified for the α-syn monomer control sample are shown as a bar graph (right). Notably, the sample treated with 1000 nM SVD-1a shows the same distribution as the monomer control. Data are shown as mean values with ±SD (n = 3).
Fig 2: De novo aggregation analysis of α-syn in the presence and absence of SVD-1a.A De novo ThT assay of 10 µM α-syn with and without 20 µM SVD-1a. ThT fluorescence progression was measured in a 96-well non-binding half-area plate (Corning, USA) with a FLUOStar plate reader (BMG labtech, GE) at λex = 448 nm and λem = 482 nm with 300 rpm continuous orbital shaking between reads. For induction of aggregation, one borosilicate bead per well was added (d = 3 mm, Hilgenberg, GE). Data are shown as mean values with ±SD (n = 5). B CD secondary structure analysis of de novo aggregation samples. Samples were incubated as described in (A) without added ThT (n = 3) and subsequently pooled for CD analysis. Far-UV ellipticity of the samples was measured in a quartz cuvette (l = 10 mm) in a J-1100 CD-spectrometer (Jasco, GE). In addition to (A), a sample with 20 µM SVD-1a alone was incubated under identical conditions and later used as a reference for the sample with α-syn and SVD-1a. For this sample (α-syn + SVD-1a (after incubation)), the SVD-1a reference subtracted CD spectrum is shown. C Samples from (A) were isolated directly after incubation and diluted in PBS pH 7.4 to a final concentration of 1 µM α-syn monomer equivalent. 5 µl diluted sample was incubated and dried on a freshly cleaved mica surface, followed by washing with ddH2O and drying using a gentle stream of N2. Analysis was performed using the NanoWizard 3 system (J-1100, JPK BioAFM, USA), recording multiple surface sections. The sections shown in (C) are representative of the observed species identified on all surface sections. D and E 10 µM α-syn monomer was incubated—analogous to the samples in (A)—with or without 5, 10, or 20 µM SVD-1a for 7 days (n = 7). The replicates were then united and loaded onto a 100 kDa MWCO centrifugal concentrator. In addition, a 10 µM α-syn sample was prepared and subjected directly to size-based fractionation. D α-Syn in the flow through (MWCO < 100 kDa) was quantified using an α-syn specific ELISA (BioLegend, Human α-Synuclein (Colorimetric), 448607, n = 3). E Retentate and flow-through samples were analyzed using SDS–PAGE with silver staining. The whole gel is shown in Supplementary Fig. 20.
Supplier Page from BioLegend for LEGEND MAX™ Human α-Synuclein (Colorimetric) ELISA Kit